Latest Funding News

Power Minerals Limited is set to list on the US OTCQB market following strong investor interest after acquiring the Gamma Heavy Rare Earths and Uranium Project in California, aiming to boost liquidity and visibility in the US capital markets.

Black Cat Syndicate reports visible antimony mineralisation in initial drill holes at Mt Clement, advancing one of Australia’s largest antimony deposits with assays due in November 2025.

Podium Minerals has achieved a metallurgical breakthrough at its Parks Reef project, delivering an 80% recovery of key metals and a 50-fold concentrate grade upgrade. The company is advancing a A$12 million capital raise to accelerate development amid soaring platinum and palladium prices.

Lincoln Minerals has appointed Chris Wilcox as CEO and Greg English as Chair, marking a strategic leadership overhaul aimed at driving exploration growth across its South Australian mineral assets.

Veris Limited has acquired Melbourne-based Mesh Livable Communities and a 50% stake in the Parsel digital platform, boosting its urban planning and digital consulting capabilities. The deal, valued at up to AUD 3.18 million plus AUD 0.5 million for equity, is expected to be earnings accretive and strengthen Veris’ presence across Australia’s property and planning sectors.

Aura Energy announces the immediate resignation of Managing Director Andrew Grove, with Executive Chair Philip Mitchell stepping in to manage operations during critical funding talks. The company remains focused on advancing its uranium and polymetallic projects in Mauritania and Sweden.

Astral Resources has secured a fully-funded joint venture with Mineral Mining Services to accelerate early gold production at its Think Big Gold Project near Kalgoorlie, promising reduced funding risks and faster cash flow.

Aquirian Limited has secured a $2.3 million strategic placement with Topgroup and signed a non-binding Memorandum of Understanding to form Drillforce WA, a 50 – 50 joint venture combining their drilling and blasting expertise.

Ardea Resources has extended its Major Project Status for the Kalgoorlie Nickel Project, reinforcing its strategic role in Australia's critical minerals sector and ensuring continued government support.

Immutep Limited’s Phase II trial of eftilagimod alfa combined with radiotherapy and KEYTRUDA in soft tissue sarcoma patients has exceeded its primary endpoint, showing a 51.5% median tumor hyalinization rate, more than triple the historical standard. These promising results, presented at ESMO 2025, suggest a potential breakthrough in a challenging cancer indication.

Vectus Biosystems has had its ASX trading suspension lifted following the disclosure of a significant transaction involving a compound from its drug library, signaling renewed investor interest.

Vectus Biosystems has agreed to sell its VB4-P5 renal fibrosis compound to Canadian biotech XORTX Therapeutics for US$3 million in shares and warrants, gaining a strategic equity position while refocusing on its cardiovascular and fibrosis pipeline.